Inventor · disambiguated record
Clifford Anders Olson
Also filed as: OLSON CLIFFORD ANDERS
15 granted patents·15 pending applications·8 citations·filing 2018–2025
87Inventor score
Top patents by PatentIndex Score
30 records- 0192US11753467B2Anti-TIM3 monoclonal antibodies and chimeric antigen receptorsNANTBIO INC·Filed 2022·Granted Sep 12, 2023·2 cites·20 claims
- 0286US11034951B2mRNA display antibody library and methodsNANTBIO INC·Filed 2019·Granted Jun 15, 2021·2 cites·7 claims
- 0384US10752682B2Anti-IL8 antibodiesNANTBIO INC·Filed 2018·Granted Aug 25, 2020·2 cites·10 claims
- 0483US11015188B2MRNA display antibody library and methodsNANTBIO INC·Filed 2018·Granted May 25, 2021·2 cites·13 claims
- 0582US2024263355A1mRNA display antibody library and methodsNANTBIO INC·Filed 2024·Application pending·0 cites
- 0679US12098201B2Anti-TIM3 monoclonal antibodies and chimeric antigen receptorsNANTBIO INC·Filed 2023·Granted Sep 24, 2024·0 cites·19 claims
- 0779US2024336684A1Anti-TIM3 monoclonal antibodies and chimeric antigen receptorsNANTBIO INC·Filed 2024·Application pending·0 cites
- 0877US2024190945A1mRNA display antibody library and methodsNANTBIO INC·Filed 2023·Application pending·0 cites
- 0976US12297247B2Fusion molecules of CTLA4 and IL-15NANTCELL INC·Filed 2023·Granted May 13, 2025·0 cites·12 claims
- 1076US2023406918A1Method of treatment of a tumor with il-8 antibodyNANTBIO INC·Filed 2023·Application pending·0 cites
- 1174US2024360191A1Targeted IL-12 Treatments and Methods to Stimulate haNK and NK92mi CellsNANTBIO INC·Filed 2024·Application pending·0 cites
- 1273US12060655B2mRNA display antibody library and methodsNANTBIO INC·Filed 2021·Granted Aug 13, 2024·0 cites·7 claims
- 1372US12409135B2Neoepitope vaccine delivery vehicle and methods of making the sameIMMUNITYBIO INC·Filed 2022·Granted Sep 9, 2025·0 cites·7 claims
- 1471US11912756B2MRNA display antibody library and methodsNANTBIO INC·Filed 2021·Granted Feb 27, 2024·0 cites·5 claims
- 1569US2024029820A1Computing affinity for protein-protein interactionNANT HOLDINGS IP LLC·Filed 2023·Application pending·0 cites
- 1669US2025339369A1Neoepitope Vaccine Delivery Vehicle and Methods of Making the SameIMMUNITYBIO INC·Filed 2025·Application pending·0 cites
- 1768US11773158B2Method of treatment of a tumor with an IL-8 antibodyNANTBIO INC·Filed 2020·Granted Oct 3, 2023·0 cites·12 claims
- 1866US2024124598A1Anti-CD30 monoclonal antibodies and chimeric antigen receptorsNANTBIO INC·Filed 2023·Application pending·0 cites
- 1965US11814436B2Anti-CD30 monoclonal antibodies and chimeric antigen receptorsNANTBIO INC·Filed 2022·Granted Nov 14, 2023·0 cites·18 claims
- 2065US2024327484A1Il-12/il-18 superkinesIMMUNITYBIO INC·Filed 2024·Application pending·0 cites
- 2164US12098177B2Targeted IL-12 treatments and methods to stimulate haNK and NK92mi cellsNANTBIO INC·Filed 2019·Granted Sep 24, 2024·0 cites·17 claims
- 2262US2025230211A1Fusion Molecules Of CTLA4 And IL-15NANTCELL INC·Filed 2025·Application pending·0 cites
- 2360US2024327492A1Modified T Cell Receptors For The Prevention And Treatment Of Viral Infections And CancerNANTCELL INC·Filed 2022·Application pending·0 cites
- 2460US2023218743A1Peptide Therapeutics Against SARS-COV-2 Spike ProteinNANTCELL INC·Filed 2022·Application pending·0 cites
- 2559US12308095B1Prediction of computational pathway circuitsNANTBIO INC·Filed 2020·Granted May 20, 2025·0 cites·8 claims
- 2652US12044687B1Method of detecting cellular reporting for therapy productionNANTBIO INC·Filed 2020·Granted Jul 23, 2024·0 cites·11 claims
- 2751US2024027462A1Arrayed peptide neoepitope generatorNANTBIO INC·Filed 2021·Application pending·0 cites
- 2851US2021284713A1Anti covid-19 therapies using cd40 ligand fusion proteinIMMUNITYBIO INC·Filed 2020·Application pending·0 cites
- 2949US12502404B1Conditional modulation of therapy using recombinant cellsNANTBIO INC·Filed 2020·Granted Dec 23, 2025·0 cites·3 claims
- 3048US2020087680A1Conditional Living SensorsNANTBIO INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Clifford Anders Olson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →